OPsumit USers Registry (OPUS)
Diseases of the Cardiovascular System | Diseases of the Lung
What is the purpose of this trial?
Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting.
- Trial withActelion Clinical Operations, Inc.
- Start Date06/28/2015
- End Date09/30/2018
- Last Updated02/22/2018
- Study HIC#1503015421REG